Study: Milani 2023, Skin Research and Technology
Efficacy and tolerability of an oral supplement containing amino acids, iron, selenium, and marine hydrolyzed collagen in subjects with hair loss (androgenetic alopecia, AGA or FAGA or telogen effluvium). A prospective, randomized, 3-month, controlled, assessor-blinded study
Citation
Milani M, Colombo F et al (2023). Skin Research and Technology. PubMed id 37357646.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Collagen for hair, nails and joints Tier B thin
B 83 people with hair loss (androgenetic alopecia or chronic telogen effluvium); 26 men, 57 women (n=83)
Randomised, assessor-blinded, 12-week trial of a tablet with hydrolysed marine collagen, taurine, cysteine, methionine, iron and selenium plus drug treatment, against drug treatment alone.
The supplement group scored higher on a photo-based global assessment at 12 weeks (1.67 against 0.66, p<0.001).
As recorded in this card: Milani M, Colombo F et al (2023), Skin Research and Technology, [primary]
Note: Not placebo-controlled and not collagen alone: it cannot show collagen helped hair loss. Ethnicity not reported in the abstract.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.